january 2008 may 2008. mission statement the fetus care biopad™’s mission is to become a world...
TRANSCRIPT
January 2008May 2008
Mission Statement
The fetus care
BioPad™’s mission is to become a world leader in the field of pre-natal care by making consumer-based medical devices that improve the pregnancy experience for women and their families.
Introducing Biopad’s Fetal Monitors
The fetus care
BioPad makes home-use fetal activity detectors and data loggers
Products are passive and non-radiating
Small, convenient, elegant and hygienic
Can be used anywhere, anytime.
Scientific evidence suggests fetal activity is a clear indicator of wellbeing
A common medical practice is a daily manual fetal kick count by the mother (‘count to 10’)
Kick count is directly linked to lower stillbirth rates (20%-30%)
Research also shows that kick counting improves the pregnancy experience
Why Fetal Movements ?
The fetus care
The fetus care
Common Poster at Doctors’ Offices
The fetus care
Monitoring Reassurance Procedure Discerning Bonding Dialog Connecting
Customer Needs
The Products – Kicker Ticker 2
The fetus care
Medical device that requires FDA approval
Consists of device (for single pregnancy) and disposable pad (one for each test)
Provides automatic and accurate monitoring Counts and stores fetal movements (trends) Shows real-time results Sounds & light indications Data output (via USB) to be shared with doctor
Each session lasts 20 minutes and can take place anywhere
The fetus careThe fetus care
Prototype Testing Completed Successfully!
The Products – Kicker Ticker 1
The fetus care
Non-medical, pregnancy experience focused
Intended to share movements with family members and friends
The Companion Egg™ responds to movements with tactile and light elements, creating tangible “event”
Does not require FDA approval
Fast time to market
Movements Light
Sounds
The Market is Significant
The fetus care
Substantial Sales Potential
KT2 costs to woman - $120
KT1 costs to woman- $80 Family set - $150 (Includes sensor & 3 Companion Eggs™)
Potential of +$100 million in income in year 5 of operations
Company Needs
$2 - $3 million second round financing
Strategic partnerships: Manufacturing Distribution Marketing
The fetus care
Hanoch KaftzanBioPad CEOT: 972.3.6093085M: 972.52.6299629F:972.3.6093089Ayalon House, 16th floor
12 Abba Hillel St. Ramat GanPO Box 25290, Tel Aviv 61251